×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

France Oxygen Therapy Equipment Market

ID: MRFR/Pharma/52294-HCR
200 Pages
Rahul Gotadki
February 2026

France Oxygen Therapy Equipment Market Research Report By Product Type (Continuous Positive Airway Pressure, Nasal Cannulas, Oxygen Concentrators, Liquid Oxygen Systems, Portable Oxygen Cylinders), By Technology (Conventional Oxygen Therapy, Hyperbaric Oxygen Therapy, Ventilation Techniques, Transcutaneous Oxygen Monitoring), By End Use (Home Care, Hospitals, Emergency Services, Long-term Care Facilities) and By Patient Type (Adult, Pediatric, Geriatric) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

France Oxygen Therapy Equipment Market Infographic
Purchase Options

France Oxygen Therapy Equipment Market Summary

As per Market Research Future analysis, the France Oxygen Therapy Equipment Market size was estimated at 154.34 $ Million in 2024. The Oxygen Therapy-equipment market is projected to grow from 160.16 $ Million in 2025 to 232.01 $ Million by 2035, exhibiting a compound annual growth rate (CAGR) of 3.7% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The France oxygen therapy-equipment market is poised for growth driven by technological advancements and increasing demand for home healthcare solutions.

  • Technological advancements in oxygen delivery systems are enhancing patient outcomes and convenience.
  • The home healthcare segment is the largest, reflecting a shift towards more personalized care solutions.
  • The fastest-growing segment is portable oxygen concentrators, driven by their ease of use and mobility.
  • Rising prevalence of respiratory disorders and increased awareness of home oxygen therapy are key market drivers.

Market Size & Forecast

2024 Market Size 154.34 (USD Million)
2035 Market Size 232.01 (USD Million)
CAGR (2025 - 2035) 3.77%

Major Players

Philips (NL), ResMed (AU), Invacare (US), Breas Medical (SE), AirSep Corporation (US), OxyGo (US), DeVilbiss Healthcare (US), GCE Healthcare (NO)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

France Oxygen Therapy Equipment Market Trends

The France Oxygen Therapy Equipment Market in France is currently experiencing notable growth. This growth is driven by an increasing prevalence of respiratory diseases and a rising awareness of the importance of oxygen therapy. The aging population, coupled with lifestyle factors such as smoking and pollution, contributes to a higher demand for oxygen therapy solutions. Furthermore, advancements in technology are leading to the development of more efficient and user-friendly devices, which may enhance patient compliance and overall treatment outcomes. As healthcare systems evolve, there is a growing emphasis on home healthcare solutions, which could further propel the market forward. In addition, regulatory frameworks in France are adapting to support innovation in the oxygen therapy-equipment market. This includes streamlined approval processes for new devices and increased funding for research and development. The integration of telemedicine and remote monitoring technologies is also becoming more prevalent, allowing healthcare providers to offer better support to patients using oxygen therapy. Overall, the landscape appears to be shifting towards more accessible and effective solutions, indicating a promising future for the oxygen therapy-equipment market in France.

Technological Advancements

The oxygen therapy-equipment market is witnessing rapid technological advancements, leading to the introduction of innovative devices. These advancements may include portable oxygen concentrators and smart inhalers, which enhance patient mobility and adherence to treatment. Such innovations are likely to improve the overall user experience and effectiveness of therapy.

Home Healthcare Growth

There is a noticeable trend towards home healthcare solutions within the oxygen therapy-equipment market. Patients increasingly prefer receiving treatment in the comfort of their homes, which may drive demand for portable and user-friendly devices. This shift could lead to a transformation in how oxygen therapy is administered.

Regulatory Support for Innovation

Regulatory bodies in France are actively supporting innovation in the oxygen therapy-equipment market. Streamlined approval processes for new technologies and increased funding for research initiatives may foster a more dynamic environment for the development of advanced therapeutic solutions.

France Oxygen Therapy Equipment Market Drivers

Increased Awareness of Home Oxygen Therapy

There is a notable rise in awareness regarding the benefits of home oxygen therapy among patients and healthcare professionals in France. This awareness is fostering a shift towards outpatient care, where patients can manage their conditions from the comfort of their homes. The oxygen therapy-equipment market is experiencing a surge in demand as more patients are prescribed home oxygen therapy. Recent surveys indicate that nearly 60% of patients prefer receiving treatment at home rather than in clinical settings. This trend is further supported by advancements in portable oxygen devices, which enhance mobility and convenience for users. Consequently, the oxygen therapy-equipment market is likely to see increased sales and innovation in home-based solutions, catering to the growing preference for at-home healthcare.

Rising Prevalence of Respiratory Disorders

The increasing incidence of respiratory disorders in France is a primary driver for the oxygen therapy-equipment market. Conditions such as chronic obstructive pulmonary disease (COPD) and asthma are becoming more prevalent, affecting a significant portion of the population. According to recent health statistics, approximately 3.5 million individuals in France are diagnosed with COPD, which necessitates the use of oxygen therapy. This growing patient base is likely to propel demand for oxygen therapy equipment, as healthcare providers seek effective solutions to manage these chronic conditions. Furthermore, the aging population, which is more susceptible to respiratory ailments, is expected to contribute to the market's expansion. As a result, the oxygen therapy-equipment market is poised for growth, driven by the urgent need for effective treatment options for respiratory disorders.

Growing Demand for Aesthetic and Functional Design

The growing demand for aesthetically pleasing and functional designs in medical equipment is emerging as a notable driver for the oxygen therapy-equipment market. Patients increasingly seek devices that not only meet their medical needs but also align with their lifestyle preferences. Manufacturers are responding to this trend by developing oxygen therapy equipment that is both visually appealing and user-friendly. For instance, portable oxygen concentrators are now available in various colors and styles, making them more attractive to users. This shift towards design-oriented products is particularly relevant in France, where consumer preferences often emphasize aesthetics. As a result, the oxygen therapy-equipment market is likely to see an increase in product offerings that cater to this demand, potentially enhancing patient satisfaction and adherence to therapy.

Technological Innovations in Oxygen Delivery Systems

Technological advancements in oxygen delivery systems are significantly influencing the oxygen therapy-equipment market. Innovations such as portable oxygen concentrators and advanced nebulizers are enhancing the efficiency and effectiveness of oxygen therapy. These devices are designed to provide patients with greater flexibility and ease of use, which is particularly appealing to the aging population in France. Manufacturers are projected to invest in research and development to create more sophisticated and user-friendly equipment, driving market growth. For instance, the introduction of smart oxygen therapy devices that monitor patient usage and adjust oxygen flow accordingly is likely to improve treatment outcomes. As a result, the oxygen therapy-equipment market is expected to benefit from these technological innovations, leading to increased adoption and market penetration.

Supportive Government Policies and Reimbursement Schemes

Supportive government policies and reimbursement schemes are playing a crucial role in shaping the oxygen therapy-equipment market. The French government has implemented various initiatives aimed at improving access to healthcare services, including oxygen therapy. These policies often include reimbursement for oxygen therapy equipment, making it more affordable for patients. Recent data suggests that approximately 75% of the costs associated with oxygen therapy are covered by health insurance, which encourages more patients to seek treatment. Additionally, the government is actively promoting the use of home healthcare solutions, further driving the demand for oxygen therapy equipment. As these supportive measures continue, the oxygen therapy-equipment market is likely to experience sustained growth, benefiting both patients and manufacturers.

Market Segment Insights

By Type: Oxygen Concentrators (Largest) vs. Oximeters (Fastest-Growing)

Within the segment of the France oxygen therapy-equipment market, Oxygen Concentrators hold the largest market share due to their efficiency and cost-effectiveness for long-term patients. The prevalence of chronic respiratory diseases has led to an increased reliance on oxygen concentrators, making them a preferred choice among healthcare providers and patients alike. Oximeters are also becoming increasingly significant in this market, providing crucial monitoring for patients requiring oxygen therapy, thus gaining market traction. The growth trend for this segment is primarily driven by the rising elderly population and the increasing incidence of respiratory ailments. Technological advancements in product design and functionality have improved both the user experience and operational efficiency, encouraging higher adoption rates. Furthermore, the integration of telehealth services has enhanced patient monitoring, contributing to the growth of oximeters as an essential tool in oxygen therapy management.

Oxygen Concentrators (Dominant) vs. Oximeters (Emerging)

Oxygen Concentrators are regarded as the dominant force within the France oxygen therapy-equipment market due to their ability to deliver a continuous supply of oxygen, thereby allowing for greater patient mobility and improved quality of life. They are also cost-effective over time compared to alternatives like oxygen cylinders. On the other hand, Oximeters have emerged as an essential tool for monitoring oxygen saturation levels in real-time, especially among patients who are newly entering oxygen therapy. Their ease of use and non-invasive nature make them highly sought after. The emerging trend of telemedicine has further propelled the demand for oximeters as healthcare providers seek efficient ways to monitor patients remotely.

By Application: Chronic Obstructive Pulmonary Disease (Largest) vs. Sleep Apnea (Fastest-Growing)

In the France oxygen therapy-equipment market, Chronic Obstructive Pulmonary Disease (COPD) represents the largest application segment. This dominance can be attributed to the high prevalence of COPD among the aging population, resulting in significant demand for effective therapeutic solutions. Conversely, the Sleep Apnea segment, while smaller, is rapidly gaining traction due to increasing awareness about sleep disorders and advancements in treatment technology that enhance patient compliance and comfort. Growth trends indicate that the overall demand for oxygen therapy equipment is driven by rising healthcare expenditure and an expanding elderly demographic susceptible to respiratory conditions. Additionally, the surge in lifestyle-related diseases further amplifies the need for effective oxygen therapy solutions, particularly for Sleep Apnea, which is expected to see significant growth as more patients seek intervention and as insurance coverage expands for these treatments.

Chronic Obstructive Pulmonary Disease (Dominant) vs. Sleep Apnea (Emerging)

Chronic Obstructive Pulmonary Disease (COPD) remains dominant in the application segment of the France oxygen therapy-equipment market, characterized by a well-established treatment protocol and a broad range of product availability, including stationary and portable oxygen concentrators. The strong market presence is supported by the critical need for symptom management in COPD patients. On the other hand, Sleep Apnea represents an emerging segment, benefitting from technological innovations like auto-adjusting CPAP devices, which enhance user experience. As healthcare providers recognize the implications of untreated Sleep Apnea on overall health, a proactive approach is being adopted, leading to increased diagnosis and treatment rates, solidifying Sleep Apnea's growing relevance in the market.

By End User: Hospitals (Largest) vs. Home Care Settings (Fastest-Growing)

In the France oxygen therapy-equipment market, the distribution of market share among the different end-user segments is quite significant. Hospitals hold the largest share, driven by high patient volumes requiring critical care and the necessity for sophisticated oxygen delivery systems. This segment is well-established, with a strong focus on advanced technologies to improve patient outcomes. In contrast, home care settings are emerging rapidly, appealing to patients requiring oxygen therapy in a more comfortable environment. The convenience and personalized care offered in home settings contribute to their increasing market share. Growth trends within the end-user segments point toward a structural shift, with the home care settings projected to expand rapidly due to aging populations and rising incidences of chronic respiratory diseases. The government's push towards home healthcare and advancements in portable oxygen devices are primary drivers of this growth, enhancing accessibility and affordability. Hospitals, while maintaining their dominant position, are also integrating telehealth technologies and innovative solutions to improve efficiency in patient management, propelling steady growth in the segment.

Hospitals (Dominant) vs. Home Care Settings (Emerging)

Hospitals remain the dominant segment in the France oxygen therapy-equipment market, characterized by their reliance on advanced medical technologies and large patient populations requiring intensive care. Their infrastructure is equipped with a wide range of oxygen therapy devices, ensuring critical patient needs are met effectively and efficiently. On the other hand, home care settings represent an emerging segment, reflecting a shift in consumer preferences towards more personalized healthcare solutions. The market in this segment is expanding rapidly, driven by technological innovations like portable oxygen concentrators and the growing acceptance of telehealth services, which enable patients to manage their conditions at home. This evolving landscape suggests a dynamic interaction between hospital capabilities and home care advancements.

By Distribution Channel: Direct Sales (Largest) vs. Online Sales (Fastest-Growing)

In the France oxygen therapy-equipment market, the distribution of market share among the channels reveals that Direct Sales holds the largest share, significantly driven by established relationships with healthcare providers and hospitals. Meanwhile, Medical Supply Distributors also contribute to the market, albeit to a lesser extent. Online Sales, although currently smaller in share, are rapidly gaining traction as consumers increasingly prefer the convenience of online platforms for purchasing medical equipment. Growth trends within this segment indicate a shift towards digitalization, with Online Sales emerging as the fastest-growing channel. This growth is propelled by increasing internet penetration and the advent of e-commerce platforms offering tailored solutions for oxygen therapy equipment. Additionally, the convenience and accessibility of online shopping are attracting both healthcare professionals and patients, enhancing the overall growth of the France oxygen therapy-equipment market.

Direct Sales (Dominant) vs. Online Sales (Emerging)

Direct Sales represent a dominant segment within the distribution channels, characterized by direct relationships with healthcare providers, allowing for personalized service and support. This channel benefits from long-standing partnerships with hospitals and clinics, ensuring a stable demand for oxygen therapy equipment. Conversely, Online Sales, while still emerging, are experiencing rapid growth owing to technological advancements and changing consumer behaviors. The online channel offers flexibility, competitive pricing, and a wider selection of products that appeal to both healthcare professionals and consumers. The shift towards e-commerce is indicative of a broader trend in the market, where convenience and accessibility are becoming paramount.

Get more detailed insights about France Oxygen Therapy Equipment Market

Key Players and Competitive Insights

The oxygen therapy-equipment market in France exhibits a dynamic competitive landscape characterized by rapid innovation and strategic partnerships. Key growth drivers include an increasing prevalence of respiratory diseases, an aging population, and advancements in technology. Major players such as Philips (NL), ResMed (AU), and Invacare (US) are strategically positioned to leverage these trends. Philips (NL) focuses on digital health solutions, enhancing patient engagement through connected devices, while ResMed (AU) emphasizes cloud-connected devices that facilitate remote monitoring. Invacare (US) is concentrating on expanding its product portfolio to include more portable oxygen solutions, thereby catering to the growing demand for mobility among patients. Collectively, these strategies foster a competitive environment that prioritizes technological advancement and patient-centric solutions.Key business tactics within this market include localizing manufacturing and optimizing supply chains to enhance responsiveness to market demands. The competitive structure appears moderately fragmented, with several players vying for market share. However, the influence of key players is substantial, as they set industry standards and drive innovation. This fragmentation allows for niche players to emerge, yet the dominance of established companies ensures that competition remains robust and focused on quality and innovation.

In October Philips (NL) announced the launch of a new line of portable oxygen concentrators designed for enhanced mobility and user-friendliness. This strategic move is significant as it aligns with the growing consumer preference for lightweight and efficient oxygen delivery systems, potentially increasing Philips' market share in the portable segment. The introduction of these devices is likely to strengthen Philips' position as a leader in innovative respiratory solutions.

In September ResMed (AU) expanded its partnership with a leading telehealth provider to integrate remote monitoring capabilities into its oxygen therapy devices. This collaboration is crucial as it enhances patient management and adherence to therapy, thereby improving health outcomes. The integration of telehealth solutions reflects a broader trend towards digital health, positioning ResMed favorably in a market increasingly focused on technology-driven care.

In August Invacare (US) completed the acquisition of a smaller competitor specializing in home healthcare products. This acquisition is strategically important as it allows Invacare to diversify its offerings and strengthen its distribution network in France. By integrating the acquired company’s innovative products, Invacare can enhance its competitive edge and respond more effectively to the evolving needs of patients and healthcare providers.

As of November current competitive trends in the oxygen therapy-equipment market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence (AI) in product development. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological innovation, reliability of supply chains, and enhanced patient experiences. This shift underscores the importance of adaptability and forward-thinking strategies in maintaining a competitive advantage.

Key Companies in the France Oxygen Therapy Equipment Market include

Industry Developments

In the France Oxygen Therapy Equipment Market, recent developments have focused on enhancing product offerings and supply chain resilience, particularly since the COVID-19 pandemic revealed vulnerabilities in healthcare systems. Companies like Air Liquide and Philips Healthcare are investing in Research and Development to improve oxygen delivery systems, catering to both hospitals and home care.

Notably, in August 2023, Linde plc announced the completion of a significant acquisition to expand its respiratory medical services, solidifying its position in the market. Growth in market valuation has been observed, with organizations like ResMed reporting a substantial increase in revenues driven by the rising demand for home care equipment, indicating a trend towards more personalized healthcare solutions.

Major industry shifts also took place in 2021, where Caire Inc. expanded its production capabilities in France, reflecting an increasing focus on domestic manufacturing. Additionally, Fisher and Paykel Healthcare has reported strategic partnerships aimed at enhancing distribution channels within France, further indicating a dynamic market landscape.

These developments are shaping the competitive environment and positioning France as a pivotal player in the global oxygen therapy equipment sector.

Future Outlook

France Oxygen Therapy Equipment Market Future Outlook

The Oxygen Therapy Equipment Market in France is projected to grow at a 3.77% CAGR from 2025 to 2035, driven by technological advancements and increasing respiratory disorders.

New opportunities lie in:

  • Development of portable oxygen concentrators for home use
  • Expansion of telehealth services for remote patient monitoring
  • Partnerships with healthcare providers for integrated therapy solutions

By 2035, the market is expected to achieve robust growth, reflecting evolving healthcare needs.

Market Segmentation

France Oxygen Therapy Equipment Market Type Outlook

  • Oxygen Concentrators
  • Oxygen Cylinders
  • Liquid Oxygen Systems
  • Oximeters

France Oxygen Therapy Equipment Market End User Outlook

  • Hospitals
  • Home Care Settings
  • Ambulatory Surgical Centers
  • Long-term Care Facilities

France Oxygen Therapy Equipment Market Application Outlook

  • Respiratory Distress
  • Sleep Apnea
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Hypertension

France Oxygen Therapy Equipment Market Distribution Channel Outlook

  • Direct Sales
  • Medical Supply Distributors
  • Online Sales

Report Scope

MARKET SIZE 2024 154.34(USD Million)
MARKET SIZE 2025 160.16(USD Million)
MARKET SIZE 2035 232.01(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 3.77% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Philips (NL), ResMed (AU), Invacare (US), Breas Medical (SE), AirSep Corporation (US), OxyGo (US), DeVilbiss Healthcare (US), GCE Healthcare (NO)
Segments Covered Type, Application, End User, Distribution Channel
Key Market Opportunities Integration of advanced telehealth solutions in the oxygen therapy-equipment market enhances patient accessibility and monitoring.
Key Market Dynamics Rising demand for home-based oxygen therapy equipment driven by aging population and regulatory support for healthcare accessibility.
Countries Covered France
Leave a Comment

FAQs

What is the expected market size of the France Oxygen Therapy Equipment Market in 2024?

The market size of the France Oxygen Therapy Equipment Market is expected to be valued at 860.25 million USD in 2024.

What will be the projected market size of the France Oxygen Therapy Equipment Market by 2035?

By 2035, the France Oxygen Therapy Equipment Market is projected to reach a value of 1,292.0 million USD.

What is the expected compound annual growth rate (CAGR) for the France Oxygen Therapy Equipment Market from 2025 to 2035?

The expected CAGR for the France Oxygen Therapy Equipment Market from 2025 to 2035 is 3.767%.

Which product type is projected to have the highest market value in 2035 in the France Oxygen Therapy Equipment Market?

In 2035, Oxygen Concentrators are projected to have the highest market value at 450.0 million USD.

What is the expected market value of Continuous Positive Airway Pressure products in 2024?

The expected market value of Continuous Positive Airway Pressure products in 2024 is 200.0 million USD.

Who are the key players in the France Oxygen Therapy Equipment Market?

The key players in the France Oxygen Therapy Equipment Market include Caire Inc., Invacare Corporation, Philips Healthcare, and Air Liquide.

What is the expected value of the Portable Oxygen Cylinders segment by 2035?

The expected value of the Portable Oxygen Cylinders segment by 2035 is 162.0 million USD.

What market trends are influencing growth in the France Oxygen Therapy Equipment Market?

Trends such as the increasing prevalence of respiratory diseases and technological advancements are influencing growth in the market.

What could be considered a major challenge for the France Oxygen Therapy Equipment Market?

A major challenge for the France Oxygen Therapy Equipment Market is the stringent regulatory environment for medical devices.

How is the market growth rate expected to vary by product segment in the France Oxygen Therapy Equipment Market?

Different product segments are anticipated to experience varied growth rates, with Oxygen Concentrators projected to grow notably in the forecast period.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions